| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |